Menu

New preclinical research shows promise for a potential treatment pathway aimed at slowing the disease process and extending survival in patients with ALS, often called Lou Gehrig’s disease, an insidious neurological condition.

Read full story

Online version with high-res image available here: https://www.cell.com/neuron/fulltext/S0896-6273(19)30970-5